查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594495

烟碱酰胺市场：依形式、产量、等级、应用分类 - 2025-2030 年全球预测

Niacinamide Market by Form (Granular, Liquid, Powder), Production (Natural, Synthetic), Grade, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年烟碱酰胺市值为7.1577亿美元，预计到2024年将达到7.456亿美元，复合年增长率为4.65%，预计到2030年将达到9.8411亿美元。

烟碱酰胺是维生素 B3 的一种，是一种多方面的成分，护肤功效而得到广泛认可，并为化妆品和个人护理行业提供显着的付加。它的需求源于其发炎、抗衰老和美白特性，吸引了寻求多功能护肤解决方案的消费者。烟碱酰胺应用于针对痤疮、色素沉着和皮肤保湿的乳霜、精华液和乳液中。由于其对神经和消化器官系统的有益作用，其最终用途范围已从护肤扩展到食品和药品。

主要市场统计
基准年[2023] 71577万美元
预测年份 [2024] 7.456 亿美元
预测年份 [2030] 98411万美元
复合年增长率（%） 4.65%

市场成长的主要驱动力是消费者对护肤和健康意识的提高、对天然和多功能成分的需求不断增长以及皮肤病患病率的上升。快速成长的美容和个人护理行业是由对有机和永续产品的强烈关注所推动的。此外，将烟碱酰胺整合到不同的产品线中可以促进从高端品牌到大众市场产品的多个切入点和用户细分。

儘管前景广阔，但市场成长面临挑战，例如化妆品配方的严格监管以及用户潜在的皮肤敏感性问题。来自透明质酸和维生素 C 等替代成分的竞争压力也带来了限制。

为了利用市场机会，公司应专注于将烟碱酰胺与补充成分结合的创新配方，以优化产品功效和消费者满意度。投资于探索头髮和指甲护理更广泛应用的研究可能会开启进一步的市场空间。强调产品采购和生产过程的透明度和永续性可以提高品牌信任度和吸引力，特别是在消费者环保意识增强的情况下。市场是充满活力和竞争的，技术创新主要反映产品交付方法的进步和配方的改进。透过响应不断变化的消费者偏好并利用护肤功效测试方面的技术进步，公司可以在这个充满活力的市场空间中占据独特的地位。

市场动态：揭示快速发展的烟碱酰胺市场的关键市场洞察

供需的动态相互作用正在改变烟碱酰胺市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 消费者对含烟碱酰胺食品或治疗糖尿病、骨关节炎和高磷酸盐血症的补充品的需求
    • 对含有烟碱酰胺的护肤品的需求不断增长
    • 增加烟碱酰胺在饲料强化的使用
  • 市场限制因素
    • 原物料供应有限且价格波动
  • 市场机会
    • 广泛的研究和开发工作，开发用于癌症治疗的烟碱酰胺治疗方法
    • 对非处方药 (OTC) 的偏好日益增长
  • 市场挑战
    • 长期使用烟碱酰胺相关的副作用和过敏反应

波特五力：驾驭烟碱酰胺市场的策略工具

波特的五力框架是了解烟碱酰胺市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解烟碱酰胺市场的外部影响

外部宏观环境因素在塑造烟碱酰胺市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解烟碱酰胺市场的竞争格局

对烟碱酰胺市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵烟碱酰胺市场供应商的绩效评估

FPNV定位矩阵是评估烟碱酰胺市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製您在烟碱酰胺市场的成功之路

烟碱酰胺市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 消费者对含烟碱酰胺食品和治疗糖尿病、骨关节炎和高磷酸盐血症补充品的需求
      • 对含有烟碱酰胺的护肤品的需求增加
      • 增加烟碱酰胺在动物饲料强化的使用
    • 抑制因素
      • 原物料供应和价格波动的限制
    • 机会
      • 广泛的研发工作开发用于癌症治疗的烟碱酰胺治疗方法
      • 人们越来越偏好市售化妆品
    • 任务
      • 长期使用烟碱酰胺相关的副作用和过敏反应
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章烟碱酰胺市场：依形式

  • 颗粒状
  • 液体
  • 粉末

第七章烟碱酰胺市场创造者

  • 自然的
  • 合成

第八章烟碱酰胺市场：依等级

  • 饲料级
  • 医药级

第九章烟碱酰胺市场：依应用分类

  • 动物营养
  • 化妆品
  • 人类营养
  • 药品

第十章美洲烟碱酰胺市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太烟碱酰胺市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲烟碱酰胺市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AIE Pharmaceuticals, Inc.
  • Bio-Tech Pharmacal, Inc.
  • Evonik Industries AG
  • Fagron Inc.
  • Foodchem International Corporation
  • Gemini Pharmaceuticals
  • Glanbia PLC
  • Koninklijke DSM NV
  • Lasons India Pvt Ltd.
  • Lonza Group AG
  • Merck KGaA
  • NutraScience Labs
  • Spectrum Chemical Mfg. Corporation
  • Vertellus LLC
  • Western Drugs Ltd.
  • Yuki Gosei Kogyo Co., Ltd.
Product Code: MRR-9E01E2DC4AC3

The Niacinamide Market was valued at USD 715.77 million in 2023, expected to reach USD 745.60 million in 2024, and is projected to grow at a CAGR of 4.65%, to USD 984.11 million by 2030.

Niacinamide, a form of vitamin B3, is a multifaceted ingredient widely recognized for its skincare benefits, adding significant value to the cosmetics and personal care industries. Its necessity arises from its anti-inflammatory, anti-aging, and brightening properties, appealing to consumers seeking multifunctional skincare solutions. Niacinamide finds applications in creams, serums, and lotions targeting acne, hyperpigmentation, and skin hydration. The end-use scope extends beyond skincare, encompassing dietary supplements and pharmaceutical products due to its beneficial impacts on the nervous and digestive systems.

KEY MARKET STATISTICS
Base Year [2023] USD 715.77 million
Estimated Year [2024] USD 745.60 million
Forecast Year [2030] USD 984.11 million
CAGR (%) 4.65%

Market growth is primarily driven by increasing consumer awareness of skincare and wellness, escalating demand for natural and versatile ingredients, and the rising prevalence of skin disorders. The burgeoning beauty and personal care industry, with a strong inclination towards organic and sustainable products, catalyzes the market expansion. Furthermore, the integration of niacinamide in diverse product lines fosters multiple entry points and user segments, from premium brands to mass-market offerings.

Despite its promising outlook, market growth faces challenges, including stringent regulations surrounding cosmetic formulations and potential skin sensitivity issues among users. Competitive pressures from alternative ingredients, such as hyaluronic acid and vitamin C, also pose limitations.

To capitalize on market opportunities, companies should focus on innovative formulations that combine niacinamide with complementary ingredients, ensuring optimal product efficacy and consumer satisfaction. Investing in research that explores its broader applications in hair and nail care could unlock additional market spaces. Emphasizing transparency and sustainability in product sourcing and production processes can enhance brand trust and appeal, especially amid increasing consumer environmental consciousness. The market is dynamic and highly competitive, with innovation predominantly reflecting advancements in product delivery methods and enhanced formulations. By staying attuned to evolving consumer preferences and leveraging technological advancements in skincare efficacy testing, businesses can carve out a unique position in this vibrant market space.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Niacinamide Market

The Niacinamide Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Consumer demand for niacinamide-containing foods or supplements for diabetes, osteoarthritis, and hyperphosphatemia
    • Increasing demand for skin care products containing niacinamide
    • Growing use of niacinamide for animal feed fortification
  • Market Restraints
    • Limited availability and volatility of the prices of ingredients
  • Market Opportunities
    • Extensive R&D activities to develop niacinamide therapies for the treatment of cancer
    • Growing preference for Over-the-counter (OTC) cosmeceuticals
  • Market Challenges
    • Adverse side effects and allergic reactions associated with the long-term use of niacinamide

Porter's Five Forces: A Strategic Tool for Navigating the Niacinamide Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Niacinamide Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Niacinamide Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Niacinamide Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Niacinamide Market

A detailed market share analysis in the Niacinamide Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Niacinamide Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Niacinamide Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Niacinamide Market

A strategic analysis of the Niacinamide Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Niacinamide Market, highlighting leading vendors and their innovative profiles. These include AIE Pharmaceuticals, Inc., Bio-Tech Pharmacal, Inc., Evonik Industries AG, Fagron Inc., Foodchem International Corporation, Gemini Pharmaceuticals, Glanbia PLC, Koninklijke DSM N.V., Lasons India Pvt Ltd., Lonza Group AG, Merck KGaA, NutraScience Labs, Spectrum Chemical Mfg. Corporation, Vertellus LLC, Western Drugs Ltd., and Yuki Gosei Kogyo Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Niacinamide Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Form, market is studied across Granular, Liquid, and Powder.
  • Based on Production, market is studied across Natural and Synthetic.
  • Based on Grade, market is studied across Feed Grade and Pharmaceutical Grade.
  • Based on Application, market is studied across Animal Nutrition, Cosmeceuticals, Human Nutrition, and Pharmaceuticals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Consumer demand for niacinamide-containing foods or supplements for diabetes, osteoarthritis, and hyperphosphatemia
      • 5.1.1.2. Increasing demand for skin care products containing niacinamide
      • 5.1.1.3. Growing use of niacinamide for animal feed fortification
    • 5.1.2. Restraints
      • 5.1.2.1. Limited availability and volatility of the prices of ingredients
    • 5.1.3. Opportunities
      • 5.1.3.1. Extensive R&D activities to develop niacinamide therapies for the treatment of cancer
      • 5.1.3.2. Growing preference for Over-the-counter (OTC) cosmeceuticals
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse side effects and allergic reactions associated with the long-term use of niacinamide
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Niacinamide Market, by Form

  • 6.1. Introduction
  • 6.2. Granular
  • 6.3. Liquid
  • 6.4. Powder

7. Niacinamide Market, by Production

  • 7.1. Introduction
  • 7.2. Natural
  • 7.3. Synthetic

8. Niacinamide Market, by Grade

  • 8.1. Introduction
  • 8.2. Feed Grade
  • 8.3. Pharmaceutical Grade

9. Niacinamide Market, by Application

  • 9.1. Introduction
  • 9.2. Animal Nutrition
  • 9.3. Cosmeceuticals
  • 9.4. Human Nutrition
  • 9.5. Pharmaceuticals

10. Americas Niacinamide Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Niacinamide Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Niacinamide Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AIE Pharmaceuticals, Inc.
  • 2. Bio-Tech Pharmacal, Inc.
  • 3. Evonik Industries AG
  • 4. Fagron Inc.
  • 5. Foodchem International Corporation
  • 6. Gemini Pharmaceuticals
  • 7. Glanbia PLC
  • 8. Koninklijke DSM N.V.
  • 9. Lasons India Pvt Ltd.
  • 10. Lonza Group AG
  • 11. Merck KGaA
  • 12. NutraScience Labs
  • 13. Spectrum Chemical Mfg. Corporation
  • 14. Vertellus LLC
  • 15. Western Drugs Ltd.
  • 16. Yuki Gosei Kogyo Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. NIACINAMIDE MARKET RESEARCH PROCESS
  • FIGURE 2. NIACINAMIDE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NIACINAMIDE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NIACINAMIDE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NIACINAMIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. NIACINAMIDE MARKET DYNAMICS
  • TABLE 7. GLOBAL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL NIACINAMIDE MARKET SIZE, BY GRANULAR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL NIACINAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL NIACINAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL NIACINAMIDE MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL NIACINAMIDE MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL NIACINAMIDE MARKET SIZE, BY FEED GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICAL GRADE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL NIACINAMIDE MARKET SIZE, BY ANIMAL NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL NIACINAMIDE MARKET SIZE, BY COSMECEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL NIACINAMIDE MARKET SIZE, BY HUMAN NUTRITION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL NIACINAMIDE MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES NIACINAMIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA NIACINAMIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY FORM, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY GRADE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM NIACINAMIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. NIACINAMIDE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. NIACINAMIDE MARKET, FPNV POSITIONING MATRIX, 2023